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On the Dynamics of TCR:CD3 Complex
Cell Surface Expression and Downmodulation
lated upon TCR ligation (Reth, 1987). These act as dock-
ing sites for SH2 domain–containing proteins, which me-
diate signal transduction and T cell activation. However,
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St. Jude Children’s Research Hospital these ITAM motifs also resemble the AP2 binding motif,
which is responsible for internalization. Clearly, not allMemphis, Tennessee 38101
†Department of Pathology YXXØ motifs can bind AP2 and mediate endocytosis,
and there is no direct evidence that the ITAMs can medi-University of Tennessee Medical Center
Memphis, Tennessee 38163 ate AP2 binding. However, it has been shown that AP2
can bind to the TCR:CD3 complex via a dileucine motif‡Fox Chase Cancer Center
Philadelphia, Pennsylvania 19111 in the CD3gd chains (Dietrich et al., 1994, 1997). How can
the TCR:CD3 complex, with at least some AP2 binding
motifs, remain stably expressed on the cell surface while
still providing access to ITAMs for tyrosine phosphory-Summary
lation?
This issue prompted us to reevaluate the extent ofTCR downmodulation following ligation by MHC:pep-
tide complexes is considered to be a pivotal event in TCR cell surface stability, internalization, and recycling.
Some early studies suggested that the TCR:CD3 com-T cell activation. Here, we analyzed the dynamics of
TCR:CD3 cell surface expression on resting and anti- plex constitutively recycles (Krangel, 1987; Minami et
al., 1987), while others found evidence for internalizationgen-activated T cells. We show that the TCR:CD3
complex is very stable and is rapidly internalized and but no recycling (Tax et al., 1987). Cell surface expres-
sion of the TCR:CD3 complex is downmodulated uponrecycled in resting T cells. Surprisingly, the internali-
zation rate is not increased following TCR ligation ligation with MHC:peptide complexes (Zanders et al.,
1983; Schonrich et al., 1991; Valitutti et al., 1995). Semi-by MHC:peptide complexes, despite significant TCR
downmodulation, suggesting that constitutive inter- nal studies have shown that a single MHC:peptide com-
plex can serially ligate z200 TCR, leading to an amplifiednalization rather than ligation-induced downmodula-
tion serves as the force that drives serial ligation. Fur- and sustained signal (Valitutti et al., 1995). This serial
engagement model has led some investigators to ex-thermore, TCR downmodulation is mediated by the
intracellular retention of ligated complexes and degra- plore the correlation between TCR downmodulation and
T cell responses. While some have shown a clear corre-dation by lysosomes and proteasomes. Thus, our data
demonstrate that ligation induces TCR downmodula- lation (Bachmann et al., 1997; Hemmer et al., 1998; Itoh
et al., 1999), others have suggested that there is notion by preventing recycling rather than inducing inter-
nalization. direct relationship (Blichfeldt et al., 1996; Cai et al.,
1997). Indeed, recent studies imply that TCR ligation
induces the downregulation of nonengaged receptorsIntroduction
(San Jose et al., 2000). Thus, it is still unclear whether
TCR internalization/downmodulation is a prerequisiteA common feature of many cell surface receptors is their
constitutive or ligand-induced endocytosis, via clathrin- for T cell signal transduction and function and whether
ligation-induced downmodulation is required to “drive”coated pits, and subsequent recycling back to the cell
surface (Brown et al., 1983; Mellman, 1996). The trans- serial engagement.
In this study, we have examined the dynamics offerrin receptor (TfR, CD71), for instance, is rapidly and
constitutively recycled through both peripheral/peri- TCR:CD3 expression and downmodulation in resting
and antigen-stimulated T cell hybridomas and CD41 Tplasmic and perinuclear recycling pathways (Hopkins,
1983; Klausner et al., 1983). This process is mediated cells from normal and TCR transgenic mice. The follow-
ing questions were addressed. (1) What is the extent ofby a tyrosine (Y)-based motif, YXXØ (X, any amino acid;
Ø, a bulky hydrophobic amino acid), in the cytoplasmic TCR recycling on resting cells? (2) How is this affected
by TCR ligation? (3) What is the intracellular location oftail of TfR that binds to the m chain of the AP2 complex,
which subsequently associates with clathrin-coated pits TCR in resting and activated T cells? (4) What is the
intracellular fate of ligated TCR?for internalization (Ohno et al., 1995; Mellman, 1996).
Conversely, Thy-1 (CD90), a phospholipid (PI)-anchored
protein, recycles very slowly (Bretscher et al., 1980). Results
The T cell receptor (TCR):CD3 complex is a large multi-
subunit complex composed of at least eight polypeptide Long-Lived TCR:CD3 Complexes Rapidly Recycle
subunits (TCRab, CD3eg, ed, and zz) (Clevers et al., 1988; in Resting T Cells
Klausner et al., 1990). The cytoplasmic tails of CD3 con- Brefeldin A (BFA) blocks anterograde transport from the
tain immune-receptor tyrosine-based activation motifs endoplasmic reticulum (ER) to the Golgi complex and
[ITAM; (D/E)X2YX2(L/I)X7YX2(L/I)], which are phosphory- causes tubulation and fusion of early endosomes with
the trans-Golgi network (TGN) (Lippincott-Schwartz et
al., 1991; Wood et al., 1991). This latter property was§ To whom correspondence should be addressed (e-mail: dario.
vignali@stjude.org). exploited to study the dynamics of TCR:CD3 cell surface
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Figure 1. TCR:CD3 Complexes Are Long
Lived and Rapidly Recycle on T Cells
The effect of BFA (10 mg/ml) and/or cyclohex-
imide (50 mg/ml) on the surface expression
of CD71, CD90, CD45, MHC class I, CD4, and
CD3 on the 3A9 T cell hybridoma and naive
CD41 T cells from B10.BR mice (CD3 only)
was determined by flow cytometry at the time
points indicated. The TCR internalization rate
was determined by linear regression analysis
following rapid exposure to BFA and is ex-
pressed as a percentage of the total surface-
labeled TCR that is internalized per minute.
Data represent the mean of three experi-
ments.
expression on the HEL 48-62–specific, H-2Ak-restricted gesting that TCR:CD3 complexes are very long lived on
resting T cells (Figure 1). Conversely, surface expressionT cell hybridoma 3A9. We compared the effect of BFA
on the expression of TCR:CD3 with TfR (CD71), Thy-1 fell rapidly following treatment with BFA and remained
low for 12 hr. This BFA-induced reduction in TCR cell(CD90), CD4, CD45, and MHC class I by flow cytometry.
In order to distinguish between the effect of BFA on the surface expression cannot be due to a block in the
transport of newly synthesized complexes migrating toprevention of endocytic versus ER:Golgi transport, cells
were also treated with cycloheximide to block protein the cell surface or the rapid degradation of internalized
TCR followed by their replacement by newly synthesizedsynthesis.
Cell surface expression of TfR, which is known to be complexes; otherwise, a similar effect would have been
seen with cycloheximide treatment. These data suggestrapidly recycled (Klausner et al., 1983), was significantly
reduced by BFA (Figure 1). Some of this reduction was that TCR:CD3 complexes are continually internalized
and recycled back to the cell surface. Similar but lessdue to the prevention of newly synthesized molecules
being transported from the ER to the Golgi, as shown by dramatic observations were also made with naive, acti-
vated (72 hr postactivation), and memory (10 days post-cycloheximide treatment. The return of TfR expression,
following BFA treatment, to normal levels is likely due activation) CD41 T cells from 3A9 TCR transgenic mice
(Figure 1; data not shown). Previous studies have shownto an increase in TfR synthesis as a consequence of
iron starvation. In contrast to TfR, Thy-1, a PI-anchored that the effect of BFA on endocytic transport is greatest
soon after treatment (Lippincott-Schwartz et al., 1991;protein that is known to recycle slowly (Bretscher et al.,
1980), and CD45 were only slightly affected by BFA and Wood et al., 1991); thus, the rate of TCR:CD3 complex
internalization was determined within the first 5 min.cycloheximide, suggesting that these molecules have a
very slow recycling and turnover rate. The loss of surface Despite the size and complexity of the TCR, it is internal-
ized reasonably fast at 2.3%/min in T cell hybridomasMHC class I was due to degradation and replacement by
newly synthesized molecules rather than any significant and 1.4%/min in naive splenic T cells (Figure 1). Given
the incomplete effect of BFA on endocytic transportlevel of recycling, as the effects of BFA and cyclohexi-
mide were comparable. In contrast, CD4 expression was (Lippincott-Schwartz et al., 1991; H. L. and D. A. A. V.,
unpublished data), it seems reasonable to propose thatreduced far more by BFA than cycloheximide (2.5-fold),
suggesting that CD4 is both recycled and degraded in the actual internalization rate may be faster.
Is the constitutive internalization of the TCR an activeresting T cells. We were surprised to find that, in several
instances, the effect of BFA alone was greater than BFA process? This possibility is supported by the dramatic
effect of BFA on CD3 expression versus Thy-1 andplus cycloheximide. This may suggest that the action
of BFA is dependent on a highly labile intermediate that CD45. We addressed this issue further by expressing
the TCR:CD3 complex on 293T cells to assess the effectrequires protein synthesis. Alternatively, this treatment
may affect proteins required for the surface stability of of BFA on mutant receptors. Wild-type TCR:CD3 com-
plexes were downmodulated on 293T cells, with slightlyCD4 or CD45, such as p56lck for the former (Pelchen-
Matthews et al., 1992). faster kinetics than seen with T cell hybridomas (Figure
2). Interestingly, removal of the CD3egd cytoplasmic do-In stark contrast to the cell surface molecules dis-
cussed above, the effect of BFA on the surface expres- mains completely abrogated TCR internalization, while
mutation of the CD3z ITAMs (Y to F) leads to a 33%sion of TCR:CD3 complexes in the 3A9 T cell hybridoma
was very different from the effect of cycloheximide. The reduction. These data suggest that motifs in the CD3
cytoplasmic domains, including the ITAMs in CD3z, ac-latter had no effect on TCR:CD3 cell surface expression,
which remained stable with no loss after 12 hr, sug- tively mediate TCR internalization.
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from the cell surface (Valitutti et al., 1995). This implied
that the ligation event triggered the internalization of the
TCR:CD3 complex. Given the high rate of TCR internal-
ization on resting T cells, we questioned whether TCR
downmodulation was due to the prevention of TCR recy-
cling rather than induction of TCR internalization.
We compared the rate of intracellular accumulation
of biotinylated TCR in naive T cells from 3A9 TCR trans-
genic mice cultured either with HEL-pulsed B cells
(LK35.2 B cell lymphoma) or B cells alone. The initial
rate of internalization in the presence or absence of
antigen was identical at 1.5%/min (0–45 min; Figure 4).
This is consistent with the BFA experiments but some-
what faster than observed previously. This could be due
to the addition of MHC class II1 B cells; however, further
studies would be required to confirm this notion. Intra-
cellular compartments were saturated with biotinylated
TCRab after 20 min, which plateaued and remained con-
stant up to 45 min. With z28% of the total surface
TCR internalized in 20 min, this would suggest that the
surface TCR pool would be replaced every hour. How-
Figure 2. The CD3 Cytoplasmic Domains Mediate Active Internal- ever, after 45 min, the fate of TCRab in the two T cell
ization of the TCR Complex
populations diverged. In unstimulated T cells, the
293T cells were transiently transfected with plasmids carrying the
amount of intracellular biotinylated TCRab decreased.3A9 TCRab chains, wild-type or tailless CD3egd, and wild-type or
Conversely, in antigen-stimulated T cells, biotinylatedITAM-mutated (Y to F) CD3z. The CD3z plasmids also contain green
TCRab accumulated to a peak after 1 hr. While this wasfluorescent protein (GFP). After 3 days, TCR1CD31GFP1 cells were
sorted, treated with BFA (10 mg/ml) for the times indicated, and a modest increase (20%), it was reproducibly observed
TCR downmodulation determined. Data represent the mean of two in five separate experiments (Figure 4B). Furthermore,
experiments. the rate of intracellular accumulation is probably offset
by the rate of TCR degradation. Densitometric analysis
showed that there was z33% more biotinylated TCRabIn order to confirm that the TCR:CD3 complex is rap-
in antigen-stimulated versus unstimulated T cells afteridly internalized on resting T cells, we also monitored
90 min, compared with z45% downmodulation of sur-TCR internalization biochemically (Smythe et al., 1992).
face TCR observed by flow cytometry. These data sug-T cells were treated with NHS-SS-biotin so that only
gest that, under physiological conditions, ligation bysurface TCR were labeled. Cells were placed in culture,
MHC:peptide complexes does not significantly acceler-and, at various time points, aliquots were removed
ate the rate of TCR internalization. This implies that TCRand treated with MESNA, a cell-impermeable reducing
downmodulation is mediated by preventing the TCRagent. This cleaves the biotin label of all surface TCR
from recycling and returning to the cell surface, ratherby reduction of the SS bond, while any internalized TCR
than by inducing its internalization.retain their biotin, as they are refractory to the cell-
impermeable MESNA. Subsequent TCR immunoprecipi-
tation and Western blotting were then used to determine Ligation by High-Density MHC:Peptide Complexes
Results in Very Rapid Downmodulation but Onlythe amount of internalized, MESNA-resistant TCR. Lin-
ear TCR internalization was observed up to 45 min with Marginal Acceleration of TCR Internalization
Given the rapid rate of constitutive TCR internalizationan internalization rate of 0.6% of surface TCR per minute
(Figure 3). Given that there is likely to be some loss of and the relatively low percentage of MHC class II mole-
cules that are loaded with the specific peptide undersignal due to the multiple steps involved and some cell
death, this rate is probably an underestimate. Subse- physiological conditions (,1%; Vignali et al., 1993), it
is likely that only a small fraction of the TCR that isquently, the amount of biotinylated TCR plateaus, which
probably indicates that the intracellular compartments internalized has been ligated. Thus, it is conceivable
that ligation does increase the TCR internalization rate,are saturated and TCR are returning to the cell surface.
From this, one can conclude that it takes z60 min to but this is not visible using physiological antigen densi-
ties. To address this issue, T cells were stimulated withtraverse the intracellular compartments (recycling time),
and z29% of the total TCR is intracellular. Taken to- an APC that expresses a single, defined MHC:peptide
complex, resulting in a substantially higher percentagegether, these data demonstrate that the TCR:CD3 com-
plex is very stable and long lived and that it is rapidly of the MHC class II molecules loaded with the HEL 48-
63 peptide (Kozono et al., 1994; Carson et al., 1997). Theinternalized and recycled on resting T cells compared
with other cell surface molecules. M12.C3 B cell line (Glimcher et al., 1985) was transfected
with constructs encoding the wild-type H-2Aka chain
and the H-2Akb chain recombinantly attached to HELTCR:CD3 Ligation Prevents TCR Return
to the Cell Surface 48-63 (designated HEL.48-63:H-2Ak.M12). In the 3A9 T
cell hybridoma, the rate of cell surface TCR downmodu-Previous studies have shown that ligation of the TCR by
MHC:peptide complexes leads to its downmodulation lation was approximately twice as fast with this transfec-
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Figure 3. The TCR:CD3 Complex Is Rapidly Internalized on Resting T Cells
(A) The rate of TCR:CD3 internalization was determined by accumulation of intracellular biotinylated TCR. B10.BR splenocytes were surface
biotinylated with NHS-SS-biotin (1 mg/ml) and, at the time points indicated, were treated with MESNA (200 mM), quenched with iodoacetamide,
and lysed in 1% Brij 97. TCRab was immunoprecipitated with anti-TCR-Cb (H57-157), immunoblotted with streptavidin-HRP, and developed
by chemiluminescence. The small amount of background signal at time 0 is due to the incomplete stripping of surface biotin. Blots were
subsequently stripped and reprobed with an anti-CD3z mAb (H146-968), followed by protein A-HRP. Data are representative of five experiments.
(B) Densitometric analysis was performed to determine the internalization rate. The background value at time 0 was subtracted, and the data
were normalized to the CD3z loading control. The internalization rate is expressed as a percentage of the total surface-labeled TCR that is
internalized per minute. Data represent the mean of five experiments.
tant compared with HEL-pulsed M12 cells expressing H-2Ak.M12 1 HEL , z100 min; a 12.5-fold difference)
versus 50% maximal TCR internalization (HEL.48-63:H-native H-2Ak (H-Ak.M12 1 HEL) (Figure 5A). However,
the internalization rate of biotinylated TCR was no faster 2Ak.M12, z13 min; H-2Ak.M12 1 HEL, z18 min; a 1.4-
fold difference). Taken together, these data suggest thatin the presence of HEL.48-63:H-2Ak.M12 (Figure 5B).
This suggested that, in T cell hybridomas, maximal liga- even in the presence of extremely high ligand densities,
which mediate substantially accelerated TCR down-tion has little effect on the TCR internalization rate.
In contrast to hybridomas, cell surface downmodula- modulation, the rate of TCR internalization is only slightly
increased. Importantly, under physiologically stimula-tion of TCR in naive CD41 T cells is dramatically in-
creased in the presence of the HEL.48-63:H-2Ak.M12 tory conditions, the bulk of the internalized TCR has not
been ligated and is thus destined for recycling back totransfectant, relative to HEL-pulsed B cells, with almost
all surface TCR lost after only 1 hr (95%; Figure 5C). In the cell surface.
contrast, stimulation with HEL-pulsed B cells mediates
z35% downmodulation after 1 hr. Despite this clear Multiple Processes Mediate the Fate of Ligated
TCR:CD3 Complexesdistinction in cell surface TCR downmodulation rates,
only a very small difference is observed in the internali- If the TCR is rapidly internalized and only a small propor-
tion is ligated, how does cell surface downmodulationzation rate of biotinylated TCRab with the two APCs
(Figures 5D and 5E). This becomes evident if one com- occur? Our data suggest that all surface TCR:CD3 com-
plexes will be recycled in 1 hr, while surface expressionpares the time required for the two stimuli to mediate
50% downmodulation (HEL.48-63:H-2Ak.M12 , z8 min; is reduced less than 20% 1 hr poststimulation. One could
Figure 4. Ligation of MHC:Peptide Complexes Induces Intracellular Retention of TCR:CD3 and Blocks Recycling
(A) TCR:CD3 internalization was determined as described in Figure 3, except that naive splenic CD41 T cells from 3A9 TCR transgenic mice
were used and incubated with either LK35.2 alone or LK35.2 prepulsed with 10 mM HEL. TCR downmodulation in untreated and biotinylated cells
was identical, suggesting that biotinylation does not affect TCR ligation of MHC:peptide complexes (data not shown). Data are representative of
five experiments.
(B) Densitometric analysis represents the mean of five experiments. The data and internalization rates are calculated as described in Fig-
ure 3.
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Figure 5. Rapid Downmodulation but Only Slightly Accelerated Internalization of TCR:CD3 Complexes following Stimulation with High MHC:HEL
Peptide Complex Densities
(A) Downmodulation of surface TCR:CD3 on the 3A9 T cell hybridoma following stimulation with either H-2Ak.M12 prepulsed with 10 mM HEL
or HEL.48-63:H-2Ak.M12 was determined by flow cytometry. Data represent the mean of two experiments.
(B) TCR:CD3 internalization was determined by the accumulation of intracellular biotinylated TCR as described in Figure 3. T cells were
cultured with H-2Ak.M12, H-2Ak.M12 prepulsed with 10 mM HEL, or HEL.48-63:H-2Ak.M12. Data are representative of three experiments.
(C) Downmodulation of surface TCR:CD3 on naive T cells from 3A9 TCR transgenic mice following stimulation with either H-2Ak.M12 prepulsed
with 10 mM HEL or HEL.48-63:H-2Ak.M12 was determined by flow cytometry. Data represent the mean of two experiments.
(D) TCR:CD3 internalization was determined by accumulation of intracellular biotinylated TCR as described in Figure 3. T cells were incubated
with either H-2Ak.M12 pulsed with 10 mM HEL or HEL.48-63:H-2Ak.M12. Data are representative of three experiments.
(E) Densitometric analysis is the mean of three experiments. The data are calculated as described in Figure 3.
hypothesize that the intracellular sorting machinery can Rab41 early endosomes. Although some CD3e was ob-
served in Rab71 late endosomes, none was seen in thedistinguish between ligated and un-ligated TCR com-
plexes, such that the former are retained intracellularly, TGN or lysosomes. The absence of CD3e in the latter
was surprising, given that a previous study with humanwhile the latter recycle back to the cell surface. Previous
studies in human T cell clones have suggested that T cells had shown that CD3z colocalizes with Lamp-1
vesicles 2 hr after antigen stimulation (Valitutti et al.,internalized CD3z is targeted to lysozomes for degrada-
tion (Valitutti et al., 1997). However, it is unclear how 1997). In their study, T cells were pretreated with bafilo-
mycin A1, which inhibits lysosomal function. Thus, it ismuch of the intracellular TCR is actually degraded in
lysozomes and whether other mechanisms exist. possible that, in the absence of such inhibitors, the TCR
is degraded too rapidly to be visualized. Alternatively,To investigate this, we first analyzed the intracellular
location of TCR:CD3 complexes by confocal micros- given that the intensity of CD3e staining is relatively high
compared with unstimulated cells, a significant propor-copy, using an anti-CD3e mAb and polyclonal Abs
against markers for early endosomes (Rab4), late endo- tion of the TCR complexes may not be degraded or
recycled back to the cell surface but instead may besomes (Rab7), the trans-Golgi network (TGN38), and
lysozomes (PP, protective protein). In unstimulated T retained in Rab41 vesicles. It should be noted that a
precise determination of how the intracellular transportcells, a significant proportion of the intracellular CD3e
appears to colocalizes with Rab41 early endosomes routes of ligated and unligated TCR differ will require the
use of higher resolution techniques that more effectively(Figure 6). Essentially, no CD3e was seen in either Rab71
late endosomes, the TGN, or lysozomes. After antigen resolve the subcompartments of the endocytic pathway.
The confocal data raised the question of where TCRstimulation, virtually all of the CD3e colocalized with
Immunity
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vent TCR recycling back to the cell surface following
antigen stimulation: intracellular retention, degradation
in late endosomes/lysozomes, and degradation in the
cytosol by proteasomes. Further studies will need to be
performed in order to quantify the relative contributions
of each of these mechanisms.
Discussion
In this study, we examined the dynamics of TCR cell
surface expression and downmodulation on resting and
activated T cells. Using two different experimental ap-
proaches, we have shown that the TCR:CD3 complex
is long lived and recycles on resting T cells, confirming
previous reports (Krangel, 1987; Minami et al., 1987).
Figure 7. Ligated TCR:CD3 Complexes Are Degraded in Both Late Our data also imply that this is an active process that
Endosomes/Lysosomes and Proteasomes requires motifs in the CD3 cytoplasmic tails, one of
TCR:CD3 internalization in splenocytes from 3A9 TCR transgenic which is a tyrosine-based motif in CD3z.
mice was determined, as described in Figure 4, in the presence or A number of studies have suggested that ligation by
absence of chloroquine (200 mM), NH4Cl (10 mM), and/or lactacystin MHC:peptide complexes induces TCR internalization
(20 mM). Note that the difference observed between the untreated,
and a subsequent downmodulation of cell surface ex-antigen-stimulated, and unstimulated controls is consistent with
pression (Valitutti et al., 1995; Bachmann et al., 1997;data in Figure 4. Data are representative of three experiments.
Valitutti et al., 1997; Hemmer et al., 1998; Itoh et al.,
1999). Given the rapid rate of TCR internalization, we
questioned whether this could be increased upon liga-is degraded. This was addressed by treating resting
and antigen-stimulated T cells with chloroquine and/or tion. Indeed, we were surprised to find that, under physi-
ological conditions, the rate of TCR internalization wasNH4Cl, which block endosomal/lysosomal acidification
and function, and lactacystin, a 26S proteasome inhibi- not accelerated by MHC:peptide ligation. Although a
very small increase was observed with extremely hightor (Fenteany et al., 1995). As expected, this treatment
had no effect on resting cells (Figure 7), which is consis- ligand densities, this could not account for the substan-
tial loss of TCR cell surface expression. Thus, the induc-tent with the long-term stability of the TCR, as revealed
by experiments with cycloheximide (Figure 1). In con- tion of internalization cannot be the primary mechanism
of mediating TCR downmodulation. Alternatively, wetrast, there was a significant increase in the amount of
biotinylated TCR in antigen-stimulated T cells treated propose that ligation induces changes in the complex
that can be interpreted by the intracellular vesicular ma-with chloroquine and NH4Cl, which is consistent with a
proportion of the TCR:CD3 complexes being degraded chinery, resulting in the redirection/retention of ligated
complexes, thus preventing their return to the cellin late endosomes/lysozomes (Figure 7). It has been
shown that these reagents can also block endocytosis; surface.
How do T cells distinguish between ligated and unli-however, the cocktail of protease inhibitors was also
found to increase in the amount of biotinylated TCR gated complexes? TCR ligation causes phosphorylation
of tyrosine residues in the ITAMs and a serine residue in(data not shown). Surprisingly, increased biotinylated
TCR was also observed in the presence of lactacystin, the CD3g chain (Cantrell et al., 1987; Weiss and Littman,
1994). This could mediate the binding of molecules thatimplicating the cytosol-resident proteasome in TCR
degradation. There did not appear to be an additive cause the redirection/retention of ligated complexes.
Furthermore, it has been shown that the ectopic expres-effect when all three drugs were combined. Notwith-
standing technical issues, it is possible that lysosomes sion of a dominant active tyrosine kinase, p56lck, results
in TCR downmodulation (D’Oro et al., 1997). However,and proteasomes are involved in degrading different
components of the same complex. For instance, it is studies with PKC inhibitors and Jurkat mutants have
suggested that serine phosphorylation of CD3g is notconceivable that the TCRab chains are degraded by
lysosomes, but this degradation cannot occur unless involved in ligand-mediated TCR downmodulation (Salio
et al., 1997; Lauritsen et al., 1998).CD3z is ubiquitinated (Hou et al., 1994) and degraded
by proteasomes. In this instance, the effects of the drugs An alternative possibility is that TCR ligation induces
a conformational change in, or physical dissociation of,would not be additive. Taken together, these data sug-
gest that there are three processes that collectively pre- the TCR:CD3 complex, revealing motifs that mediate
Figure 6. TCR:CD3 Complex Is Predominantly Present in the Rab41 Early Endosomes in Resting and Stimulated T Cells
(A) 3A9 T cell hybridoma was incubated with either H-2Ak.M12 or HEL.48-63:H-2Ak.M12 at 378C for 1 hr. Confocal microscopy was performed
using an anti-CD3e mAb (green) and polyclonal Abs against markers (all in red) for early endosomes (Rab4), late endosomes (Rab7), the trans-
Golgi network (TGN38), and lysozomes (PP, protection protein). Colocalization of CD3 and the markers is yellow/orange in the “mix” panels.
The panels shown are representative of all T cells examined. In some panels, the marker-positive, CD3e-negative B cells can be seen (middle/
top cell in the Rab7/H-2Ak.M12 panel).
(B) An enlarged view of selected “mix” panels is presented. Scale bars are also shown.
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the redirection/retention of ligated receptors. Two mo- degraded by proteasomes (Huppa and Ploegh, 1997;
tifs have previously been shown to act as potent degra- Yang et al., 1998). It has also been shown that the CD3z
dation signals: the YXXØ motifs within the ITAMs and and CD3d chains are ubiquitinated in a tyrosine kinase–
a dileucine motif in the CD3g and CD3d cytoplasmic dependent manner following TCR ligation (Cenciarelli et
domains (Johnson and Kornfeld, 1992; Dietrich et al., al., 1992, 1996). Despite the fact that lactacystin is a
1994). More recently, CD3e has been found to contain remarkably selective drug (Fenteany et al., 1995), we
an endocytosis signal (Borroto et al., 1999). While it has cannot rule out the possibility that degradation in lyso-
been shown that cells that lack the cytoplasmic domains somes is affected. However, it has been shown that
of both CD3g and CD3d fail to downmodulate the TCR lactacystin has no effect on the lysosomal degradation
following anti-CD3 stimulation, downmodulation in re- of endocytosed proteins (Craiu et al., 1997). Taken to-
sponse to MHC:peptide ligation was not blocked (Luton gether, these data suggest that there are multiple mech-
et al., 1997a; Legendre et al., 1999). These motifs could anisms by which ligated TCR:CD3 complexes are pre-
be revealed following a conformational change or physi- vented from returning to the cell surface. Further
cal dissociation of the complex upon ligation. Interest- experiments will be required to determine precisely how
ingly, we have recently found that TCR ligation induces and to what degree each of these mechanisms contrib-
the physical separation of the CD3z chain from the rest ute to the TCR retention/degradation process.
of the TCR:CD3 complex (H. L., A. Szymczak, M. R., What is the physiological role of TCR:CD3 recycling
D. L. W., and D. A. A. V., unpublished data). While the and downmodulation? As the rate of TCR internalization
CD3z remains on the cell surface, the TCRabCD3eged is similar with or without ligation, it seems unlikely that
complex is internalized. We and others have shown that internalization per se is a prerequisite for T cell signal
CD3z is required to maintain stable TCR cell surface transduction and activation. Furthermore, the significant
expression (Dietrich and Geisler, 1998; H. L., A. Szymc- time lag between tyrosine phosphorylation of the TCR
zak, and D. A. A. V., unpublished data). Furthermore, complex and surface downmodulation also suggests
data have emerged for a dynamic relationship between that the latter is not required for T cell activation. Indeed,
CD3z and the rest of the TCR:CD3 complex, such that several groups have failed to find a correlation between
CD3z is transported to the Golgi independently of the TCR downmodulation and T cell responses (Blichfeldt
rest of the TCR complex and is freely exchanged with et al., 1996; Cai et al., 1997). Our studies have shown
newly synthesized CD3z at the cell surface (Ono et al., that APCs pulsed with antigen or transfected with MHC
1995; Dietrich et al., 1999). Thus, our model for the mo- molecules containing recombinantly attached peptides
lecular mechanism of TCR downmodulation occurs in give rise to significantly different rates of TCR downmod-
two stages: first, TCR ligation induces the separation of ulation but comparable levels of IL-2 production (Carson
CD3z from the rest of the complex, and, second, these et al., 1997; H. L. and D. A. A. V., unpublished data).
partial complexes reveal motifs that are recognized by Given the possibility that the same tyrosine motifs
the intracellular vesicular machinery and are retained may mediate both recycling and signal transduction, it
and/or redirected for degradation. Therefore, ligation is possible that recycling is a necessary consequence
causes an intracellular prevention of TCR recycling of having at least some of the tyrosine residues accessi-
rather than an induction of TCR internalization. The rela- ble for phosphorylation. We would suggest that the rapid
tive contribution of these motifs (known and unknown) rate of internalization is required to drive serial ligation
to recycling and downmodulation has yet to be deter- and facilitate the release of MHC:peptide complexes by
mined. TCR (Valitutti et al., 1995). Finally, we believe that the
In this study, we addressed two other important is- most likely function of TCR downmodulation is to protect
sues: intracellular location and the fate of ligated and T cells from overstimulation (Cai et al., 1997). By analogy,
unligated TCR:CD3 complexes. Rapidly recycling pro- it has been shown that TCR downmodulation is an effec-
teins such as TfR are typically transported through a
tive means of tolerance to an extrathymically expressed
periplasmic/peripheral recycling pathway, which pre-
MHC class I transgene (Schonrich et al., 1991). It is also
dominantly consists of Rab41 vesicles (Mellman, 1996).
conceivable that the lack of cell surface TCR may limitOur studies have suggested that the TCR:CD3 complex
the extent of antigen-induced cell death (AICD) causedis predominantly found in Rab41 vesicles, which is con-
by T cell restimulation prior to a sufficient resting period.sistent with previous findings demonstrating the pres-
ence of TCR in early endosomes (Luton et al., 1997b).
Experimental ProceduresAlthough a small proportion of TCR is associated with
Rab71 late endosomes, none was detected in lyso-
Downmodulation and Flow Cytometrysomes. However, evidence was obtained for the degra-
The assay for downmodulation of TCR:CD3 was performed as de-
dation of TCR:CD3 complexes in lysosomes, consistent scribed previously (Vignali and Vignali, 1999). In brief, the 3A9 T cell
with previous observations (Valitutti et al., 1997). hybridoma (Allen et al., 1985) (5 3 104; 100 ml) or splenocytes from
Surprisingly, a proportion of the internalized TCR was 3A9 TCR transgenic mice (gift from Mark Davis, Stanford University,
also degraded in the cytosol by proteasomes, as evi- Palo Alto, CA) (Ho et al., 1994) (5 3 105; 100 ml) were cultured in
flat-bottom 96-well microtiter plates (in quadruplicate for each timedenced by inhibition with lactacystin. While this was an
point) with one of the following: (1) H-2Ak.M12 (M12.C3.F6; Nelsonunexpected result, there is increasing support for the
et al., 1992) 6 10 mM HEL overnight prepulse; (2) HEL.48-63:H-role of proteasomes in the degradation of transmem-
2Ak.M12 (Carson et al., 1997); or (3) BFA (10 mg/ml; Epicenter Tech-
brane proteins (Lord, 1996; Brodsky and McCracken, nologies, Madison, WI) and/or cycloheximide (50 mg/ml; Sigma
1999). Interestingly, recent studies have shown that un- Chemical, St. Louis, MO). At the time points indicated, cells were
paired TCRa and CD3d chains are translocated from the transferred to V-well microtiter plates for flow cytometry. The effi-
ciency of cycloheximide treatment was verified by metabolic label-ER into the cytosol where they are ubiquitinated and
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ing with [35]S-methionine and measuring the reexpression of CD4 CD32 (FcgIII/IIR, Fc Block; PharMingen) in 5% normal mouse serum
in PBS for 30 min. Cells were then incubated (45 min in humidifiedon pronase-treated cells (Wiest et al., 1997).
Flow cytometry was performed, as detailed previously, using a chamber at 378C) with a biotinylated anti-CD3e mAb (500A2; Phar-
Mingen) and rabbit polyclonal Abs against either Rab4 (gift fromFACScan or a FACSCalibur (Becton Dickinson, San Jose, CA) (Car-
son et al., 1997; Vignali and Vignali, 1999). Cells were stained with Marino Zerial, EMBL, Heidelberg, Germany; Cormont et al., 1996),
Rab7 (gift from Marino Zerial; Chavrier et al., 1990), TGN38 (gift fromone of the following FITC-labeled mAbs: anti-CD3e, anti-CD4, anti-
CD45, anti-CD71/TfR, anti-CD90/Thy-1, or anti-H-2Kk (PharMingen, George Banting, Bristol University, England; Luzio et al., 1990), or
protective protein (PP; gift from Alessandra D’Azzo, St. Jude Chil-San Diego, CA). Cells were stained with anti-H-2Aak-PE to gate out
B cells and with PI for live/dead cell gating (T cells were .90% dren’s Research Hospital; Rottier et al., 1998). Cells were stained
with streptavidin-Alexa 488 and anti-rabbit Ig-Alexa 594 (Molecularviable in all experiments). In experiments with splenocytes, cells
were also stained with anti-CD4.APC to gate in T cells. The percent- Probes, Eugene, OR) for 45 min at 378C. Slides were mounted using
Aqua Poly/Mount (Polysciences, Inc., Warrington, PA) and analyzedage downmodulation of TCR:CD3 was determined from the median
values, using the unstimulated controls as reference. on a Leica TCS NT SP confocal microscope (Leica, Germany). Im-
ages were taken using a 1003 lens with 23 zoom at a resolution
of 1024 3 1024 (83 scan). The optical thickness (z section) was 0.4Transient Transfection of 293T Cells
m. Data were processed using Leica TCS NT (Leica, Germany) and293T cells (human embryonic kidney cells; provided by David Balti-
Adobe PhotoShop (Adobe, San Jose, CA).more, Caltech, and Elio Vanin, SJCRH) were incubated in 10 cm
plates at 2 3 106/plate overnight at 378C. DMEM (470 ml) was mixed
Acknowledgmentswith 30 ml Fugene 6 transfection reagent (Roche, Indianapolis, IN)
for 5 min at room temperature. The following plasmids were used:
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and William Walker for the 3A9 TCR transgenic mice, Elio Vanin andin pCI.IRES.GFPneo. DNA (2 mg of each chain) was mixed with
David Baltimore for 293T cells, and Emil Unanue for M12.C3.F6. WeFugene/DMEM and incubated for 15 min at room temperature. The
also wish to thank Gopal Murti and the Scientific Imaging Sharedmixture was incubated with the cells overnight at 378C and replaced
Resource for assistance with the confocal microscopy and mem-with fresh medium the next day. On day 4, GFP/TCR/CD31 cells
bers of the Vignali lab for constructive criticisms and comments.were sorted (stained with anti-TCR.Vb8.1/2.PE and anti-CD3.APC)
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39480), a Cancer Center Support CORE grant (5 P30 CA21765-17),was added at 10 mg/ml, and, at different time points, cells were
and the American Lebanese Syrian Associated Charities (ALSAC).stained with anti-TCR.Cb.Cy-Chrome and TCR surface downmodu-
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Surface Biotinylation and MESNA Treatment
Cells were surface biotinylated as previously described (Smythe et References
al., 1992; Wiest et al., 1995). In brief, T cells (2 3 108/ml for spleno-
cytes from B10.B10 or 3A9 TCR transgenic mice or 2 3 107/ml for Allen, P.M., McKean, D.J., Beck, B.N., Sheffield, J., and Glimcher,
hybridomas) were washed three times in HBSS and labeled with 1 L.H. (1985). Direct evidence that a class II molecule and a simple
mg/ml NHS-SS-biotin (Pierce Chemical, Rockford, IL) HBSS for 30 globular protein generate multiple determinants. J. Exp. Med. 162,
min on ice. Excess biotin was quenched and the cells washed three 1264–1274.
times with 25 mM lysine/HBSS. The T cells (2 3 107 per IP for Bachmann, M.F., Oxenius, A., Speiser, D.E., Mariathasan, S., Hen-
splenocytes, 5 3 106 per IP for hybridomas) were cultured at 378C gartner, H., Zinkernagel, R.M., and Ohashi, P.S. (1997). Peptide-
either alone or with APC ([1] LK35.2 [murine B cell lymphoma; induced T cell receptor down-regulation on naive T cells predicts
H-2Akd] 6 10 mM HEL overnight prepulse, [2] H-2Ak.M12 6 10 mM agonist/partial agonist properties and strictly correlates with T cell
HEL, [3] HEL.48-63:H-2Ak.M12; all at 5 3 106 per IP). In certain activation. Eur. J. Immunol. 27, 2195–2203.
experiments, cells were incubated with a proteasome inhibitor (lac-
Blichfeldt, E., Munthe, L.A., Rotnes, J.S., and Bogen, B. (1996). Dualtacystin, 10 mM; Kamiya Biomedical Company, Seattle, WA) and/or
T cell receptor T cells have a decreased sensitivity to physiologicallysosomal degradation inhibitors (NH4Cl, 10 mM; and chloroquine, ligands due to reduced density of each T cell receptor. Eur. J. Immu-200 mM; Sigma). At each time point, cells were treated three times
nol. 26, 2876–2884.with 2-mercaptoethanesulfonic acid (MESNA) (10 mM; Sigma) on
Borroto, A., Lama, J., Niedergang, F., Dautry-Varsat, A., Alarcon, B.,ice for 30 min. In some experiments, cells were treated with 200 mM
and Alcover, A. (1999). The CD3 epsilon subunit of the TCR containsMESNA on ice for 5 min. Cells were then washed with iodoacetamide
endocytosis signals. J. Immunol. 163, 25–31.(IAA) (Sigma) twice before lysis in 1% Brij97 (polyoxyethylene 10
oleyl ether; Sigma). Bretscher, M.S., Thomson, J.N., and Pearse, B.M. (1980). Coated
pits act as molecular filters. Proc. Natl. Acad. Sci. USA 77, 4156–
4159.Immunoprecipitation and Immunoblotting
Immunoprecipitation and immunoblotting were performed as pre- Brodsky, J.L., and McCracken, A.A. (1999). ER protein quality control
viously described (Vignali and Strominger, 1994; Liu and Vignali, and proteasome-mediated protein degradation. Semin. Cell Dev.
1999). In brief, cells were lysed with 1% Brij 97 and immunoprecipi- Biol. 10, 507–513.
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